A high intake of lean protein and reduced consumption of sugar, fat, and processed carbohydrates is often recommended to help counteract some side effects of the injections
What plan sponsors are watching Alberta Blue Cross identifies several factors shaping GLP-1 plan costs through 2026: Expanded potential uses beyond diabetes and obesity, including MASH and OSA [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] A robust pipeline of new GLP-1 therapies under development [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Shift toward longer-acting and oral formulations [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] A semaglutide generic expected mid-2026 [Source: benefitscanada.com/benefits/health-benefits/expanded-use-of-glp-1s-a-major-driver-of-drug-plan-costs-in-2026-report/] Canadians assessing their options can review our insurance coverage checker or visit the FAQ for pricing and regulatory context
From the Lab Related Blog Posts Apr 13, 2026 About blank
The subcutaneous injection sites commonly used for semaglutidethe abdomen, thigh, and upper armcontain networks of these tiny vessels, making some degree of vascular contact nearly unavoidable
For someone who wants a minimally invasive addition to their existing diet and exercise program, the risk-to-reward ratio is very low because the risks are essentially zero
